Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▲Subject
 10.5.2024Teva B.V. (TEV-NL-4)8238CSunitinib Teva 25 mg tvrdé kapsuly (cps dur 30x1x25 mg (blis.PVC/Aclar/PVC/Al))15.7.2024R
 29.4.2024Gilead Sciences Ireland UC (GLS-2)2193BZydelig 150 mg filmom obalené tablety (tbl flm 60x150 mg (fľ.HDPE))1.7.2024Z
 2.2.2024M.C.M. Klosterfrau Vertriebsgesellschaft mbH (MCM-1)66928MELISANA Klosterfrau (sol pdr 1x155 ml (fľ.skl.))1.7.2024R
 15.5.2024Menarini International Operations Luxembourg S.A. (MNR)7875CSkudexa 75 mg/25 mg granulát na perorálny roztok vo vrecku (gro sac 15x75 mg/25 mg (vre.papier/Al/PE))1.7.2024U
 28.11.2023Zentiva, k.s. (ZNT-1)0925DEverio 25 mikrogramov/125 mikrogramov/dávka inhalačná suspenzia v tlakovom obale (sus inh 1x120 dávok (nád.tlak.Al))30.6.2024Z
 6.5.2024Boehringer Ingelheim International GmbH (BOE)15722BERODUAL N (sol inh 1x10 ml/200 dávok (obal kovový))30.6.2024Z
 2.5.2024Teva B.V. (TEV-NL-4)8602BAtomoxetine Actavis 40 mg (cps dur 28x40 mg (blis.PVC/PVDC/PVC/Al))20.6.2024R
 11.3.2024Aspen Pharma Trading Limited (ASE-1)75182Alkeran inj (plv iol 1x50 mg+10 ml solv. (liek.inj.skl.))20.6.2024R
 17.4.2024Novartis Slovakia s.r.o. (NVL-2)2854CMiflonide Breezhaler 400 (plv icd 60(6x10)x400 µg (blis.PVC/PVDC/Al+ 1 inhalátor Breezhaler))18.6.2024Z
 9.5.2024Novartis Europharm Limited (NEH-IE)20584Votrient 400 mg filmom obalené tablety (tbl flm 30x400 mg (fľ.HDPE))15.6.2024Z
 3.5.2024Bracco Imaging SPA (BRL-5)5726EVueway 0,5 mmol/ml injekčný roztok (sol inj 1x50 ml (liek.inj.skl.))7.6.2024U
 23.4.2024B.Braun Melsungen AG (BME)26923Kaliumchlorid B. Braun 7,45 % (con inf 20x20 ml (amp.PE))3.6.2024R
 10.4.2024TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3267BPramipexol Teva Pharma 0,26 mg (tbl plg 30x0,26 mg (blis.OPA/Al/PVC/Al))1.6.2024R
 10.4.2024Teva B.V. (TEV-NL-4)9742DTrabectedin Teva 0,25 mg prášok na koncentrát na infúzny roztok (plc ifc 1x0,25 mg (liek.inj.skl.+ochran.obal))1.6.2024R
 25.3.2024Glenmark Pharmaceuticals s.r.o. (GLM-CZ)7139BEzetimibe Glenmark 10 mg tablety (tbl 98x10 mg (blis.PVC/Aclar/Al))1.6.2024Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)